MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study

1. Ou, S.H.
2. Moreno Garcia, V.
3. Gil Bazo, I.
4. Prenen, H.
5. Moreno, I.
6. Johnson, M.
7. Castañón Álvarez, E.
8. Nagasaka, M.
9. Adeyemi, S.
10. Barasa, B.
11. Bol, K.
12. Doze, P.
13. Engbers, A.
14. Joe, A.K.
15. Stalbovskaya, V.
16. Laus, G.
17. Call, J.